Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Gilead Sciences, Inc. (GILD) had Normalized Pre-Tax Income of $9.80B for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$29.44B |
|
$8.51B |
|
$6.23B |
|
$23.21B |
|
$19.42B |
|
$10.02B |
|
$-226.00M |
|
$9.80B |
|
|
Normalized Pre-Tax Income |
$9.80B |
$8.51B |
|
$8.51B |
|
$8.51B |
|
$8.51B |
|
$10.02B |
|
$10.02B |
|
1.24B |
|
1.25B |
|
$6.84 |
|
$6.78 |
|
| Balance Sheet Financials | |
$19.89B |
|
$5.61B |
|
$39.14B |
|
$59.02B |
|
$11.81B |
|
-- |
|
$24.59B |
|
$36.41B |
|
-- |
|
$-2.67B |
|
$22.62B |
|
1.24B |
|
| Cash Flow Statement Financials | |
$10.02B |
|
$-4.79B |
|
$-7.75B |
|
$9.99B |
|
$7.56B |
|
$-2.43B |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|